Cargando…
Antithyroglobulin Antibody as a Marker of Successful Ablation Therapy in Differentiated Thyroid Cancer
The aim of this study was to determine the role of antithyroglobulin antibody (ATA) serum as a marker of successful I-131 ablation therapy in differentiated thyroid cancer (DTC) patients with low serum thyroglobulin (Tg). A retrospective study was conducted on 60 patients (10 males and 50 females)....
Autores principales: | Dewi, Ayu Rosemeilia, Darmawan, Budi, Kartamihadja, Achmad Hussein Sundawa, Hidayat, Basuki, Masjhur, Johan S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314657/ https://www.ncbi.nlm.nih.gov/pubmed/28217014 http://dx.doi.org/10.4103/1450-1147.174714 |
Ejemplares similares
-
The effect of retinoic acid in the ability of cold solid thyroid nodule to take up radioactive iodine: A preliminary study
por: Lim, Andreas, et al.
Publicado: (2019) -
Automated Bone Scan Index as Predictors of Survival in Prostate Cancer
por: Wiyanto, Joko, et al.
Publicado: (2017) -
Change in Antithyroglobulin Antibody Levels is a Good Predictor of Responses to Therapy in Antithyroglobulin Antibody-Positive Pediatric Papillary Thyroid Carcinoma Patients
por: Xi, Chuang, et al.
Publicado: (2022) -
Association of antithyroglobulin antibodies with the development of thyroid dysfunction induced by nivolumab
por: Kimbara, Shiro, et al.
Publicado: (2018) -
Correlation between ER, PR, HER-2, and Ki-67 with the risk of bone metastases detected by bone scintigraphy in breast cancer patients: A cross sectional study
por: Afkari, Hanif, et al.
Publicado: (2021)